Material Agreements

Airspan Networks Holdings Inc. amended Limited Waiver and Consent, Seventh Amendment to Senior Secured Convertible Note Purchase and Guarantee Agreement and Reaffirmation of Note Documents (the NPA Amendment) with the purchasers party thereto and the administrative and collateral agent (effective 2024-03-07).

“In connection with the Sixth A&R Credit Agreement, the Company modified the terms of its Senior Secured Convertible Note Purchase and Guarantee Agreement, dated July 30, 2021 (as further amended, amended and restated, restated, supplemented or otherwise modified from time to time prior to the Effective Date, the “Note Purchase Agreement”) pursuant to the Limited Waiver and Consent, Seventh Amendment to Senior Secured Convertible Note Purchase and Guarantee Agreement and Reaffirmation of Note Documents, dated the Effective Date (the “NPA Amendment”), among the Company, ANI, certain of its subsidiaries as guarantors, the purchasers party thereto and the administrative and collateral agent.”

Airspan Networks Holdings Inc. amended Limited Waiver and Consent, Sixth Amendment and Restatement of Credit Agreement and Reaffirmation of Loan Documents (the Sixth Amendment and Restatement Agreement) with DBFIP ANI LLC, as administrative agent and collateral agent valued at $18 million (effective 2024-03-07).

“On March 7, 2024 (the “Effective Date”), Airspan Networks Holdings Inc., a Delaware corporation (the “Company”), entered into the Limited Waiver and Consent, Sixth Amendment and Restatement of Credit Agreement and Reaffirmation of Loan Documents (the “Sixth Amendment and Restatement Agreement”) among the Company, as Holdings (in such capacity, “Holdings”), Airspan Networks Inc., a Delaware corporation (“ANI”), as the Borrower (in such capacity, the “Borrower”), certain subsidiaries of the Company, as guarantors, the lenders party thereto (collectively, the “Lenders”) and DBFIP ANI LLC, as administrative agent and collateral agent (together with its successors and assigns in such capacities, the “Agent”).”

Astra Space, Inc. entered into Warrant Exchange Agreement with each holder of Warrants.

“a warrant exchange agreement, by and among Parent, Merger Sub, and each holder of Warrants (the “ Warrant Exchange Agreement ”)”

Astra Space, Inc. entered into Noteholder Conversion Agreement with each holder of Convertible Notes.

“a noteholder conversion agreement, by and among Parent, Merger Sub, and each holder of Convertible Notes (the “ Noteholder Conversion Agreement ”)”

Astra Space, Inc. entered into Agreement and Plan of Merger with Apogee Parent Inc., Apogee Merger Sub Inc. (effective 2024-03-07).

“the Company, Apogee Parent Inc., a Delaware corporation (“ Parent ”), and Apogee Merger Sub Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“ Merger Sub ”), entered into an Agreement and Plan of Merger (the “ Merger Agreement ”)”

Rackspace Technology, Inc. entered into First Lien Credit Agreement with Citibank, N.A., administrative agent and collateral agent (effective 2024-03-12).

“the New Borrower entered into a First Lien Credit Agreement, dated March 12, 2024 (the “ New Credit Agreement ”), among Rackspace Finance Holdings, LLC (“ New Holdings ”), the New Borrower, the lenders and issuing banks party thereto and Citibank, N.A., as administrative agent and collateral agent”

Aprea Therapeutics, Inc. entered into Securities Purchase Agreement with certain investors valued at aggregate gross proceeds of approximately $16.0 million (effective 2024-03-11).

“On March 11, 2024, Aprea Therapeutics, Inc. (the "Company") entered into a securities purchase agreement (the "Securities Purchase Agreement") with certain investors (the "Purchasers"), pursuant to which the Company agreed to issue and sell to the Purchasers, and the Purchasers agreed to purchase from the Company (i) 1,687,712 shares (the "Private Placement Shares") of the Company’s Common Stock, par value $0.001 per share ("Common Stock") at a purchase price of $7.29 per share, (ii) pre-funded Common Stock purchase warrants (the "Pre-Funded Warrants") to purchase an aggregate of up to 507,076 shares of Common Stock at an exercise price of $0.001 per share, (iii) Tranche A Common Stock purchase warrants to purchase up to 1,097,394 shares of Common Stock at an exercise price of $7.29 per share (the "Tranche A Warrants"), and (iv) Tranche B Common Stock purchase warrants to purchase up to 1,097,394 shares of Common Stock at an exercise price of $9.1125 per share (the "Tranche B Warrants"”

Powerfleet, Inc. entered into Facilities Agreement with FirstRand Bank Limited (acting through its Rand Merchant Bank division) valued at $85 million (effective 2024-03-07).

“On March 7, 2024, PowerFleet, Inc. (the “Company”), together with I.D. Systems, Inc. (“IDSY”) and Movingdots GmbH (“Movingdots” and, collectively with the Company and IDSY, the “Obligors”), each a wholly owned subsidiary of the Company, entered into a Facilities Agreement (the “Facilities Agreement”) with FirstRand Bank Limited (acting through its Rand Merchant Bank division) (“RMB”), pursuant to which RMB has agreed to provide the Company with two term loan facilities in an aggregate principal amount of $85 million, comprised of two facilities in the aggregate principal amount of $42.5 million and $42.5 million, respectively (the “Term A Facility” and “Term B Facility,” respectively, and, collectively, the “Term Facilities”).”

PLIANT THERAPEUTICS, INC. amended Amended and Restated Loan and Security Agreement with Oxford Finance LLC and the lenders valued at $150.0 million (effective 2024-03-11).

“On March 11, 2024 (the “Effective Date”), Pliant Therapeutics, Inc. (the “Company”) entered into an Amended and Restated Loan and Security Agreement (“Agreement”) by and among the Company, the lenders from time to time party thereto (each a “Lender” and collectively, the “Lenders”) and Oxford Finance LLC, in its capacity as collateral agent (in such capacity, the “Agent”), which amends and restates, in its entirety, the Loan and Security Agreement, dated as of May 4, 2022”

International Money Express, Inc. entered into Share Repurchase Agreement valued at approximately $3.3 million (effective 2024-03-11).

“On March 11, 2024, International Money Express, Inc. (the “ Company ”) entered into a share repurchase agreement (the “ Share Repurchase Agreement ”) with Robert W. Lisy (the “ Stockholder ”), the Company’s Chief Executive Officer, President and Chairman of the Board of Directors (the “Board”), for the purchase of 175,000 shares of the Company’s common stock”

Alcoa Corp entered into Scheme Implementation Deed with Alumina Limited (effective 2024-03-11).

“On March 11, 2024 (Eastern Daylight Time) / March 12, 2024 (Australian Eastern Daylight Time), Alcoa Corporation, a Delaware corporation (“ Alcoa ”), AAC Investments Australia 2 Pty Ltd, an Australian proprietary company limited by shares and an indirect wholly owned subsidiary of Alcoa (“ Alcoa Bidder ”), and Alumina Limited, an Australian public company limited by shares and listed on the Australian Securities Exchange (“ Alumina ”), entered into a Scheme Implementation Deed (the “ Deed ”), pursuant to which, subject to the satisfaction or waiver of the conditions set forth therein, Alcoa Bidder will acquire all Alumina ordinary shares on issue and outstanding”

Delek Logistics Partners, LP entered into Underwriting Agreement with Truist Securities, Inc., BofA Securities, Inc., Raymond James & Associates, Inc. valued at Sale of 3,116,884 common units at $38.50 per unit, plus option for up to 467,532 additional units (effective 2024-03-07).

“On March 7, 2024, Delek Logistics Partners, LP (the “Partnership”) entered into an underwriting agreement (the “Underwriting Agreement) by and among the Partnership, Delek Logistics GP, LLC, a Delaware limited liability company and the general partner of the Partnership, and Truist Securities, Inc., BofA Securities, Inc. and Raymond James & Associates, Inc., as joint book-running managers and representatives of the several underwriters named on Schedule A thereto (collectively, the “Underwriters”), pursuant to which the Underwriters agreed to sell to the public 3,116,884 common units representing limited partner interests in the Partnership (“Firm Units”) at a price of $38.50 per Unit (the “Offering”).”

Norwegian Cruise Line Holdings Ltd. terminated Secured Notes Indenture with the holders of the Secured Notes valued at NCLC repurchased all outstanding 9.75% Senior Secured Notes due 2028 in aggregate principal amount o (effective 2024-03-11).

“On March 11, 2024, in connection with the settlement of the Repurchase, the Trustee cancelled the aggregate principal amount outstanding under the Secured Notes and confirmed that NCLC had satisfied and discharged its obligations under the Secured Notes Indenture.”

Norwegian Cruise Line Holdings Ltd. amended Third Amended and Restated Commitment Letter with funds managed by affiliates of Apollo Global Management (the Apollo Funds) valued at up to $650.0 million of senior unsecured notes due five years after the issue date (effective 2024-03-11).

“On February 23, 2024, NCL Corporation Ltd. (“NCLC”), a subsidiary of Norwegian Cruise Line Holdings Ltd., entered into a third amended and restated commitment letter (the “Amended Commitment Letter”) with funds managed by affiliates of Apollo Global Management (the “Apollo Funds”), which became effective on March 11, 2024 and which amends, restates and supersedes the second amended and restated commitment letter, dated February 22, 2023, among NCLC and the Apollo Funds.”

Streamex Corp. entered into Promissory Note with an investor valued at $500,000 (effective 2024-03-07).

“On March 7, 2024, BioSig Technologies Inc. (the “Company”) issued a Promissory Note (the “Note”) to an investor for $500,000.”

Avinger Inc amended Fourth Amendment to Lease with HCP LS Redwood City, LLC valued at $1,272,432 in annual base rent (effective 2024-03-06).

“On March 6, 2024, we entered into the Fourth Amendment to Lease with the Landlord (the “Fourth Amendment”), which amended the Lease to extend the lease term with respect to the 400 Building for a period of one year.”

NS Wind Down Co., Inc. entered into Asset Purchase Agreement with an affiliate of Patient Square Capital valued at $220,000,000 (effective 2024-03-10).

“On March 10, 2024, the Company entered into an asset purchase agreement (the “Asset Purchase Agreement”) with an affiliate of Patient Square Capital (“Patient Square”) to sell substantially all of the assets of the Company and its subsidiaries (the “Business”) for a cash purchase price of $220,000,000 (the “Purchase Price”)”

Calumet Specialty Products Partners, L.P. amended Amendment with Wilmington Trust, National Association (effective 2024-03-08).

“In connection with the issuance of the Notes, on March 8, 2024, the Issuers and the guarantors under the Indenture (other than Calumet Montana Refining, LLC) entered into an amendment (the “Amendment”) to (i) the Amended and Restated Collateral Trust Agreement (the “Collateral Trust Agreement”) with Wilmington Trust, National Association, as collateral trustee (in such capacity, the “Collateral Trustee”), the Trustee and the representatives of certain other holders of Parity Lien Obligations (as defined in the Collateral Trust Agreement) and (ii) the Second Amended and Restated Security and Pledge Agreement with the Collateral Trustee.”

Calumet Specialty Products Partners, L.P. entered into Indenture with Wilmington Trust, National Association valued at $200.0 million aggregate principal amount (effective 2024-03-07).

“On March 7, 2024, Calumet Specialty Products Partners, L.P. (the “Partnership”) and Calumet Finance Corp. (“Finance Corp.” and, together with the Partnership, the “Issuers”) issued $200.0 million aggregate principal amount of a new series of the Issuers’ 9.25% Senior Secured First Lien Notes due 2029 (the “Notes”) in a private placement transaction in reliance on an exemption from registration under Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”).”

Lazard Group LLC amended Tenth Supplemental Indenture with The Bank of New York Mellon valued at $400,000,000 (effective 2024-03-12).

“The Notes were issued pursuant to a tenth supplemental indenture, dated March 12, 2024, (the “Tenth Supplemental Indenture”), between the Company and The Bank of New York Mellon, as trustee, to an indenture, dated May 10, 2005 (the “Indenture”), between the Company and The Bank of New York Mellon (formerly known as The Bank of New York), as trustee.”

Lazard Group LLC entered into Underwriting Agreement with Citigroup Global Markets Inc., as representative of the several underwriters valued at $400,000,000 (effective 2024-03-06).

“On March 6, 2024, the Company entered into an underwriting agreement (the “Underwriting Agreement”) with Citigroup Global Markets Inc., as representative of the several underwriters listed on Schedule I thereto (collectively, the “Underwriters”), pursuant to which the Company agreed to sell and the Underwriters agreed to purchase, subject to and upon terms and conditions set forth therein, the Notes.”

NCL CORP Ltd. terminated Secured Notes Indenture with U.S. Bank Trust Company, National Association valued at $250.0 million 9.75% Senior Secured Notes due 2028 repurchased and cancelled (effective 2024-03-11).

“On March 11, 2024, in connection with the settlement of the Repurchase, the Trustee cancelled the aggregate principal amount outstanding under the Secured Notes and confirmed that NCLC had satisfied and discharged its obligations under the Secured Notes Indenture.”

NCL CORP Ltd. entered into third amended and restated commitment letter with funds managed by affiliates of Apollo Global Management valued at $650.0 million senior unsecured notes due five years after issue date (effective 2024-03-11).

“On February 23, 2024, NCL Corporation Ltd. (“NCLC”) entered into a third amended and restated commitment letter (the “Amended Commitment Letter”) with funds managed by affiliates of Apollo Global Management (the “Apollo Funds”), which became effective on March 11, 2024 and which amends, restates and supersedes the second amended and restated commitment letter, dated February 22, 2023, among NCLC and the Apollo Funds.”

Lazard, Inc. entered into Underwriting Agreement with Citigroup Global Markets Inc., as representative of the several underwriters (effective 2024-03-06).

“On March 6, 2024, Lazard Group entered into an underwriting agreement (the “Underwriting Agreement”) with Citigroup Global Markets Inc., as representative of the several underwriters listed on Schedule I thereto (collectively, the “Underwriters”), pursuant to which Lazard Group agreed to sell and the Underwriters agreed to purchase, subject to and upon terms and conditions set forth therein, the Notes.”

Lazard, Inc. entered into Tenth Supplemental Indenture with The Bank of New York Mellon valued at $400,000,000 (effective 2024-03-12).

“On March 12, 2024, Lazard Group LLC (“Lazard Group”), a subsidiary of Lazard, Inc., completed its previously announced offering of an aggregate principal amount of $400,000,000 of Lazard Group’s 6.000% Senior Notes due 2031 (the “Notes”) in a registered public offering pursuant to Lazard Group’s shelf registration statement on Form S-3 (Registration No. 333-263578).”

CalEthos, Inc. entered into Exchange Agreement with 14 holders valued at $5,417,459.50 (effective 2023-12-11).

“Between December 11, 2023 and February 20, 2024, CalEthos Inc. (the “Company”) entered into a series of exchange subscription agreements (each, an “Exchange Agreement” and collectively, the “Exchange Agreements”) with 14 holders (each, a “Holder”) of the Company’s outstanding promissory notes and, in certain cases, related outstanding stock purchase warrants, pursuant to which the Company and the Holders agreed to exchange their promissory notes, and, if applicable, related stock purchase warrants, for shares of the Company’s common stock, par value $0.001per share (the “Common Stock”).”

PhaseBio Pharmaceuticals Inc entered into Plan Support and Settlement Agreement with SFJ Pharma X, Inc. (effective 2024-03-06).

“On March 6, 2024, the Company and SFJ executed and entered into a Plan Support and Settlement Agreement (the “Settlement Agreement”) to resolve the Motion to Allow, the Objection, and related matters.”

XEROX CORP entered into Indenture with U.S. Bank Trust Company, National Association valued at $350 million (effective 2024-03-11).

“the Company entered into an Indenture, dated March 11, 2024 (the “Indenture”), with Xerox Corporation and Xerox Business Solutions, LLC, as guarantors, and U.S. Bank Trust Company, National Association, as trustee.”

CoreCivic, Inc. entered into Supplemental Indenture with Equiniti Trust Company, LLC and the subsidiary guarantors set forth therein valued at $500 million aggregate principal amount of 8.250% senior unsecured notes due 2029 (effective 2024-03-12).

“the supplemental indenture dated as of March 12, 2024 (the “Supplemental Indenture”), by and among the Company, the Trustee, and the subsidiary guarantors set forth therein (the “Guarantors”).”

CoreCivic, Inc. entered into Base Indenture with Equiniti Trust Company, LLC valued at $500 million aggregate principal amount of 8.250% senior unsecured notes due 2029 (effective 2024-03-12).

“On March 12, 2024, CoreCivic, Inc., a Maryland corporation (the “Company”), completed the previously announced public offering (the “Notes Offering”) of $500 million aggregate principal amount of 8.250% senior unsecured notes due 2029 (the “Notes”), which are fully and unconditionally guaranteed, on a senior unsecured basis, by the Guarantors (as defined below) (the “Guarantees”).”

INTEST CORP entered into Lease Agreement with Elettra Real Estate S.r.l valued at €231,312 (effective 2024-03-12).

“In connection with the Purchase Agreement, Alfamation has entered into a lease agreement (the “Lease Agreement”) by and between Alfamation and Elettra Real Estate S.r.l , a limited liability company incorporated under the Laws of Italy (the “Landlord”).”

INTEST CORP entered into Purchase Agreement with Mauro Arigossi and Elettra S.S. valued at approximately €20 million (effective 2024-03-12).

“On March 12, 2024 inTEST Corporation (the “Company”) entered into a stock purchase agreement (the “Purchase Agreement”) by and among inTEST Italy, Inc., a wholly owned subsidiary of the Company (“Buyer”), Mauro Arigossi (“Arigossi”), and Elettra S.S., a company incorporated under the Laws of Italy (“Elettra”, and together with Arigossi, each a “Seller” and collectively, the “Sellers”).”

DYNAVAX TECHNOLOGIES CORP entered into Office/Laboratory Lease with Emery Station West, LLC valued at lease of approximately 75,662 sq ft at 5959 Horton Street, Emeryville, California (effective 2018-09-17).

“on September 17, 2018, Dynavax Technologies Corporation (the “Company”) entered into an Office/Laboratory Lease (“Master Lease”) with Emery Station West, LLC (“Master Landlord”) to lease approximately 75,662 square feet of office/laboratory space located at 5959 Horton Street, Emeryville, California (“Premises”).”

DYNAVAX TECHNOLOGIES CORP terminated Termination and Release Agreement with Zymergen Inc. and Metagenomi, Inc. valued at termination of Zymergen Sublease effective upon satisfaction of conditions precedent (effective 2024-02-22).

“the Company, Zymergen and Metagenomi, Inc. (“Metagenomi”) entered into that certain Termination and Release Agreement dated February 22, 2024 (the “Termination Agreement”), pursuant to which the Zymergen Sublease will terminate effective as of the date the conditions precedent set forth in the Termination Agreement have been satisfied.”

DYNAVAX TECHNOLOGIES CORP entered into Sublease with Metagenomi, Inc. valued at initial monthly base rate $493,354.08 with 50% abatement through June 30, 2024, term through March 3 (effective 2024-03-07).

“On March 7, 2024, the Company, as sublandlord, entered into a sublease (the “Sublease”) with Metagenomi, as subtenant, for the Premises.”

WESTINGHOUSE AIR BRAKE TECHNOLOGIES CORP entered into Twelfth Supplemental Indenture to the Indenture dated as of August 8, 2013, for 5.611% Senior Notes due 2034 with Computershare Trust Company, National Association; U.S. Bank Trust Company, National Association valued at $500,000,000 aggregate principal amount of 5.611% Senior Notes due 2034 (effective 2024-03-11).

“On March 11, 2024, Westinghouse Air Brake Technologies Corporation (the “Company”) completed a public offering and sale of $500,000,000 aggregate principal amount of the Company’s 5.611% Senior Notes due 2034 (the “notes”).”

Enveric Biosciences, Inc. entered into Purchase Agreement with certain institutional investors (effective 2024-03-08).

“On March 8, 2024, Enveric Biosciences, Inc., a Delaware corporation (the “Company”) entered into a series of common stock purchase agreements (the “Purchase Agreement”) for the issuance in a registered direct offering of 228,690 shares of the Company’s common stock, par value $0.01 per share (the “Shares”), to certain institutional investors.”

FOMO WORLDWIDE, INC. terminated a credit facility with Thermo Communications Funding, LLC valued at $1,074,276.15 (effective 2024-01-04).

“On January 4, 2024, Thermo Communications Funding, LLC (“Thermo”) defaulted us and our subsidiary SMARTSolution Technologies, Inc. (“SST”), terminated its senior secured asset backed lending agreement executed with us on February 28, 2022, and subsequently obtained a confession of judgment against us and certain of our subsidiaries.”

HEALTHPEAK PROPERTIES, INC. amended Sales Agreement with J.P. Morgan Securities LLC, Robert W. Baird & Co. Incorporated, Barclays Capital Inc., BNP Paribas Securities Corp., BofA Securities, Inc., BTIG, LLC, Capital One Securities, Inc., Credit Agricole Securities (USA) Inc., Goldman Sachs & Co. LLC, Jefferies LLC, Mizuho Securities USA LLC, Morgan Stanle valued at up to $1,500,000,000 (effective 2024-03-11).

“On March 11, 2024, Healthpeak Properties, Inc., a Maryland corporation (the “Company”), and Healthpeak OP, LLC, a Maryland limited liability company (the “operating company”), entered into an amendment (the “Amendment”) to the “at-the market” equity offering sales agreement (the “Sales Agreement”) with each of J.P. Morgan Securities LLC, Robert W. Baird & Co. Incorporated, Barclays Capital Inc., BNP Paribas Securities Corp., BofA Securities, Inc., BTIG, LLC, Capital One Securities, Inc., Credit Agricole Securities (USA) Inc., Goldman Sachs & Co. LLC, Jefferies LLC, Mizuho Securities USA LLC, Morgan Stanley & Co. LLC, RBC Capital Markets, LLC, Regions Securities LLC, Scotia Capital (USA) Inc., TD Securities (USA) LLC, Truist Securities, Inc. and Wells Fargo Securities, LLC”

IPALCO ENTERPRISES, INC. entered into IPALCO Purchase Agreement with J.P. Morgan Securities LLC, PNC Capital Markets LLC and U.S. Bancorp Investments, Inc., as representatives valued at $400 million (effective 2024-03-08).

“on March 8, 2024, IPALCO entered into a purchase agreement (the “IPALCO Purchase Agreement”) with the Representatives, as representatives of the several initial purchasers named therein (the “IPALCO Initial Purchasers”), relating to the sale by IPALCO of $400 million aggregate principal amount of senior secured notes (the “Notes”) at an annual interest rate of 5.750%.”

IPALCO ENTERPRISES, INC. entered into AES Indiana Purchase Agreement with J.P. Morgan Securities LLC, PNC Capital Markets LLC and U.S. Bancorp Investments, Inc., as representatives valued at $650 million (effective 2024-03-07).

“On March 7, 2024, the principal subsidiary of IPALCO Enterprises, Inc. (“IPALCO”), Indiana Power & Light Company, d/b/a AES Indiana (“AES Indiana”) entered into a purchase agreement (the “AES Indiana Purchase Agreement”) with J.P. Morgan Securities LLC, PNC Capital Markets LLC and U.S. Bancorp Investments, Inc., as representatives (collectively, the “Representatives”) of the several initial purchasers named therein (the “AES Indiana Initial Purchasers”), relating to the previously announced offering by AES Indiana of $650 million aggregate principal amount of First Mortgage Bonds (the “Bonds”) at an annual interest rate of 5.700%.”

China Solar & Clean Energy Solutions, Inc. entered into Asset Purchase Agreement with Easy Modular Manufacturing, Inc valued at cash consideration and contingent consideration (effective 2024-03-05).

“On March 5, 2024, China Solar & Clean Energy Solutions, Inc (the “Company) entered into an asset purchase agreement (the “Asset Purchase Agreement”) with Easy Modular Manufacturing, Inc (“Easy Modular Manufacturing”) for the purchase of the asset Easy Nano-Void Injection System Modular (the “Product”).”

PAR TECHNOLOGY CORP entered into Scheme Implementation Agreement with TASK Group Holdings Limited valued at AUD$0.81 per TASK Share or 0.015 shares of PAR common stock per TASK Share (effective 2024-03-08).

“On March 8, 2024 (Eastern Standard Time) / March 9, 2024 (Sydney Time), PAR and TASK Group Holdings Limited, an Australian public company limited by shares and listed on the Australian Securities Exchange (“TASK”), entered into a Scheme Implementation Agreement (the “ SIA ”), pursuant to which, subject to the satisfaction or waiver of the conditions set forth therein, PAR or its nominee (“ PAR Acquiror ”) will acquire all TASK ordinary shares (the “ TASK Shares ”) pursuant to a court-approved scheme of arrangement under Part 5.1 of Australia’s Corporations Act 2001 (Cth) (“ Corporations Act ”) (the “ TASK Scheme ” and such acquisition, the “ TASK Transaction ”).”

PAR TECHNOLOGY CORP entered into Purchase Agreement with Longshore Capital Fund I, L.P. valued at $170 million in cash and 441,598 common shares (effective 2024-03-08).

“On March 8, 2024 (the “ Signing/Closing Date ”), PAR Technology Corporation, a Delaware corporation (“ PAR ”), and ParTech, Inc., a New York corporation (the “ ParTech ”) and a wholly owned subsidiary of PAR, entered into a Purchase Agreement (the “ Purchase Agreement ”) with the persons identified as Company Sellers on the signature pages thereto, Longshore Capital Fund I, L.P., a Delaware limited partnership (collectively, the “ Stuzo Sellers ”), and Longshore Capital Management, LLC, a Delaware limited liability company, in its capacity as the Seller Representative.”

EQT Corp entered into Agreement and Plan of Merger with Equitrans Midstream Corporation (effective 2024-03-10).

“On March 10, 2024, EQT Corporation, a Pennsylvania corporation (“EQT”), Humpty Merger Sub Inc., a Delaware corporation and an indirect wholly owned subsidiary of EQT (“Merger Sub”), Humpty Merger Sub LLC, a Delaware limited liability company and an indirect wholly owned subsidiary of EQT (“LLC Sub”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Equitrans Midstream Corporation, a Pennsylvania corporation (“Equitrans”).”

NIKE, Inc. terminated Prior 364‐Day Credit Agreement with the banks, financial institutions and other lenders signatory thereto valued at up to $1.0 billion (effective 2024-03-08).

“On March 8, 2024, concurrently with the Company’s entry into the 364-Day Credit Agreement described in Item 1.01 hereof, the Company terminated the existing Credit Agreement dated March 10, 2023, which provided for up to $1.0 billion of borrowings in U.S. Dollars pursuant to a 364‐day unsecured revolving credit facility, with the banks, financial institutions and other lenders signatory thereto (the “Prior 364‐Day Credit Agreement”).”

NIKE, Inc. entered into 364‐Day Credit Agreement with Bank of America, N.A., as administrative agent, and the other financial institutions named therein as lenders valued at up to $1.0 billion (effective 2024-03-08).

“On March 8, 2024, NIKE, Inc. (the “Company”) entered into a Credit Agreement with Bank of America, N.A., as administrative agent, and the other financial institutions named therein as lenders (the “364‐Day Credit Agreement”).”

RenX Enterprises Corp. entered into Credit Agreement with Bryan Leighton Revocable Trust Dated December 13th, 2023 valued at up to the maximum amount of $250,000 (effective 2024-03-01).

“On March 1, 2024 Safe and Green Development Corporation (the "Company") entered into a credit agreement (the “Credit Agreement”) with the Bryan Leighton Revocable Trust Dated December 13th, 2023 (the “Lender”) pursuant to which the Lender agreed to provide the Company with a line of credit facility (the “Line of Credit”) up to the maximum amount of $250,000”

Lexeo Therapeutics, Inc. entered into Common Stock Purchase Agreement with certain qualified institutional buyers and institutional accredited investors valued at approximately $95 million (effective 2024-03-11).

“On March 11, 2024, Lexeo Therapeutics, Inc. (the “ Company ”) entered into a Common Stock Purchase Agreement (the “ Purchase Agreement ”) for a private placement (the “ Private Placement ”) with certain qualified institutional buyers and institutional accredited investors (each, a “ Purchaser ” and collectively, the “ Purchasers ”).”

Signing Day Sports, Inc. amended Amendment No. 1 to Strategic Alliance Agreement with SAJE Enterprises LLC (DBA Elite Development Program Soccer) (effective 2024-03-08).

“On March 8, 2024, Signing Day Sports, a Delaware corporation (the “Company”), entered into Amendment No. 1 to Strategic Alliance Agreement (the “Amendment to the Strategic Alliance Agreement”) with SAJE Enterprises LLC (DBA Elite Development Program Soccer), a New Jersey limited liability company (“EDP”).”